HealthEquity, Inc. HQY
At closeNov 6, 2026, 4:00 PM EST
After hours · Nov 6, 4:00 PM ET
- YTD
- +13.12%
- 1 year
- +11.74%
- Market cap
- 8.57B
- Revenue (ttm)
- 1.36B
- Profit margin
- 17.36%
- EPS (ttm)
- 2.77
- Shares out
- 82.72M
- P/E ratio
- 37.41
- Forward P/E
- 18.78
- YTD return
- +13.12%
- 1-year return
- +11.74%
- Volume
- 674.40K
- Avg volume
- 870.77K
- Open
- 101.42
- Previous close
- 103.46
- Day's range
- 100.54 – 104.10
- 52-week range
- 72.76 – 110.26
- Beta
- 0.19
- Analysts
- Strong Buy
- Price target
- 120.67 (+16.4%)
- Earnings date
- Dec 1, 2026
5m +2.22 (+2.19%)
Key statistics
- Enterprise value
- 9.27B
- PEG ratio
- 1.27
- Price / sales
- 6.29
- Price / book
- 4.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 7.60%
- Free cash flow
- 397.51M
- Total cash
- 256.00M
- Total debt
- 971.02M
- Return on equity
- 11.43%
- Short % of float
- 9.54%
- 50-day average
- 95.32
- 200-day average
- 89.40
Analyst view
Consensus: strong buy
- Target (low)
- 108.00
- Target (mean)
- 120.67
- Target (high)
- 142.00
- Strong buy5
- Buy10
- Hold0
- Sell0
- Strong sell0
Next earnings
Dec 1, 2026
Expected Dec 1, 2026. Consensus EPS estimate 1.15.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 1, 2026 | Oct 31, 2026 | 1.15 | — | — | — |
| Aug 27, 2026 | Jul 31, 2026 | 1.19 | 1.24 | +0.05 | +4.20% |
| May 28, 2026 | Apr 30, 2026 | 1.11 | 1.24 | +0.13 | +11.71% |
| Mar 17, 2026 | Jan 31, 2026 | 0.89 | 0.95 | +0.06 | +6.74% |
| Dec 3, 2025 | Oct 31, 2025 | 0.912 | 1.01 | +0.10 | +10.75% |
| Sep 2, 2025 | Jul 31, 2025 | 0.914 | 1.08 | +0.17 | +18.16% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | BMO Capital | main | Outperform | Outperform |
| Sep 18, 2026 | Barclays | main | Overweight | Overweight |
| Aug 31, 2026 | Deutsche Bank | main | Buy | Buy |
| Aug 28, 2026 | BTIG | reit | Buy | Buy |
| Jul 24, 2026 | BTIG | main | Buy | Buy |
| Jun 3, 2026 | RBC Capital | reit | Outperform | Outperform |
About HealthEquity, Inc.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- healthequity.com
News
HealthEquity Schedules Third Quarter Earnings Release Date 
BLCO vs. HQY: Which Stock Is the Better Value Option? 
BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125 
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115 
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142 
12 Health Care Stocks Moving In Thursday's Intraday Session 
Crude Oil Moves Higher; Dollar General Shares Gain After Upbeat Q2 Earnings - HealthEquity Reports Q2 2027 Results: Full Earnings Call Transcript
HealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate - HealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est
Your note
Sign in to keep a note on HQY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CUTLER SCOTT RAYMOND | Chief Executive Officer | Stock Award(Grant) | Mar 24, 2026 | 182,574 |
| DILLON ADRIAN T | Director | Sale | Aug 24, 2026 | 62,395 |
| FIORE MICHAEL HENRY | Officer | Sale | Jul 9, 2026 | 52,244 |
| KESSLER JON | Former | Sale | Jun 5, 2025 | 0 |
| LADD DELANO W IV | General Counsel | Sale | May 27, 2026 | 91,141 |
| LUCANIA JAMES M | Chief Financial Officer | Stock Award(Grant) | Mar 24, 2026 | 111,849 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.63% | 11,277,914 | 1.17B | Jun 29, 2026 |
| Wasatch Advisors LP | 8.48% | 7,011,469 | 726.60M | Sep 29, 2026 |
| Morgan Stanley | 5.50% | 4,547,219 | 471.23M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.91% | 4,057,643 | 420.49M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.40% | 3,640,776 | 377.29M | Jun 29, 2026 |
| State Street Corporation | 3.92% | 3,241,046 | 335.87M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.60% | 2,977,919 | 308.60M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.05% | 2,523,016 | 261.46M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.65% | 2,191,650 | 227.12M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.20% | 1,822,161 | 188.83M | Jun 29, 2026 |
| WASATCH FUNDS TRUST-Wasatch Core Growth Fund | 2.00% | 1,656,051 | 171.62M | Sep 29, 2026 |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 1.80% | 1,488,394 | 154.24M | Jun 29, 2026 |